PubMed:25097285
Annnotations
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 286-293 | HP_0000739 | denotes | anxiety |
| T2 | 326-336 | HP_0000716 | denotes | depressive |
NEUROSES
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 37-49 | CHEBI_36791 | denotes | escitalopram |
| T2 | 526-538 | CHEBI_36791 | denotes | escitalopram |
| T3 | 1062-1074 | CHEBI_36791 | denotes | escitalopram |
| T4 | 1452-1464 | CHEBI_36791 | denotes | escitalopram |
| T5 | 1470-1482 | CHEBI_36791 | denotes | escitalopram |
| T6 | 54-68 | CHEBI_83527 | denotes | desvenlafaxine |
| T7 | 504-518 | CHEBI_83527 | denotes | desvenlafaxine |
| T8 | 1097-1111 | CHEBI_83527 | denotes | desvenlafaxine |
| T9 | 1419-1433 | CHEBI_83527 | denotes | desvenlafaxine |
| T10 | 123-127 | PATO_0000610 | denotes | open |
| T11 | 398-402 | PATO_0000610 | denotes | open |
| T12 | 128-133 | CHEBI_35209 | denotes | label |
| T13 | 403-408 | CHEBI_35209 | denotes | label |
| T14 | 167-176 | CHEBI_28790 | denotes | serotonin |
| T15 | 208-217 | CHEBI_28790 | denotes | serotonin |
| T16 | 167-176 | CHEBI_350546 | denotes | serotonin |
| T17 | 208-217 | CHEBI_350546 | denotes | serotonin |
| T18 | 186-196 | CHEBI_35222 | denotes | inhibitors |
| T19 | 198-202 | CHEBI_50949 | denotes | SSRI |
| T22 | 347-350 | CHEBI_566274 | denotes | MDD |
| T23 | 391-396 | CHEBI_24433 | denotes | group |
| T24 | 1075-1080 | CHEBI_24433 | denotes | group |
| T25 | 1112-1117 | CHEBI_24433 | denotes | group |
| T26 | 1255-1260 | CHEBI_24433 | denotes | group |
| T27 | 410-415 | PATO_0000083 | denotes | phase |
| T28 | 551-565 | CHEBI_35469 | denotes | antidepressant |
| T30 | 795-799 | PATO_0001470 | denotes | rate |
| T31 | 795-799 | PATO_0000161 | denotes | rate |
| T32 | 84-94 | PM3425 | denotes | depression |
| T33 | 636-646 | PM3425 | denotes | Depression |
| T34 | 84-94 | PM3425 | denotes | depression |
| T35 | 636-646 | PM3425 | denotes | Depression |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_25097285_2_0 | 157-196 | expanded | denotes | Selective serotonin reuptake inhibitors |
| SS2_25097285_2_0 | 198-202 | abbr | denotes | SSRI |
| SS1_25097285_2_1 | 208-252 | expanded | denotes | serotonin-norepinephrine reuptake inhibitors |
| SS2_25097285_2_1 | 254-258 | abbr | denotes | SNRI |
| SS1_25097285_2_2 | 320-345 | expanded | denotes | major depressive disorder |
| SS2_25097285_2_2 | 347-350 | abbr | denotes | MDD |
| SS1_25097285_5_0 | 674-703 | expanded | denotes | Hamilton Anxiety Rating Scale |
| SS2_25097285_5_0 | 705-710 | abbr | denotes | HAM-A |
| AE1_25097285_2_0 | SS1_25097285_2_0 | SS2_25097285_2_0 | abbreviatedTo | Selective serotonin reuptake inhibitors,SSRI |
| AE1_25097285_2_1 | SS1_25097285_2_1 | SS2_25097285_2_1 | abbreviatedTo | serotonin-norepinephrine reuptake inhibitors,SNRI |
| AE1_25097285_2_2 | SS1_25097285_2_2 | SS2_25097285_2_2 | abbreviatedTo | major depressive disorder,MDD |
| AE1_25097285_5_0 | SS1_25097285_5_0 | SS2_25097285_5_0 | abbreviatedTo | Hamilton Anxiety Rating Scale,HAM-A |